We would like to thank Dr. Pike-Lee for the inquiry regarding our study [
]. We would like to explain the factors included in our score, especially early-onset myasthenia gravis (EOMG) or thymoma-associated myasthenia gravis (TAMG) and the incorrect number of patients.
- Kanai T.
- Uzawa A.
- Kawaguchi N.
- et al.
Predictive score for oral corticosteroid-induced initial worsening of seropositive generalized myasthenia gravis.
J. Neurol. Sci. 2019; 396: 8-11
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of the Neurological Sciences
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Predictive score for oral corticosteroid-induced initial worsening of seropositive generalized myasthenia gravis.J. Neurol. Sci. 2019; 396: 8-11
- Clinical features and treatment status of adult myasthenia gravis in Japan.Clin Exp Neuroimmunol. 2014; 5: 84-91
Published online: July 31, 2019
Accepted: July 17, 2019
Received: July 15, 2019
© 2019 Elsevier B.V. All rights reserved.